Potential therapeutic effect of yeast killer toxin.
Experimental infections were produced in guinea pigs, rabbits and dogs with lesions similar to those seen in human seborrheic dermatitis and otitis externa by cutaneous application of cultures of Malassezia furfur and M. pachydermatis. Infected animals were treated by topical application of a concentrated yeast killer toxin (Hansenula anomala UCSC 25F). Clinical recovery as well as negative mycological test cultures of infected animals proved to the clearly associated with the treatment by the killer toxin.
D000287:Administration, Topical; D000818:Animals; D004285:Dogs; D005656:Fungal Proteins / Q000627:therapeutic use*; D006168:Guinea Pigs; D006801:Humans; D055646:Killer Factors, Yeast; D008290:Malassezia / Q000302:isolation & purification; D009183:Mycotoxins / Q000008:administration & dosage / Q000302:isolation & purification / Q000627:therapeutic use*; D011817:Rabbits; D012871:Skin Diseases / Q000188:drug therapy* / Q000473:pathology; D014010:Tinea Versicolor / Q000188:drug therapy* / Q000473:pathology
D005656:Fungal Proteins; D055646:Killer Factors, Yeast; D009183:Mycotoxins